Published on November 2021 | Hyperuricemia
Gout is one of the most complex and leading types of crystal arthropathy that can cause inflammatory arthritis. Mostly, it is linked with diminished quality of life related to health and wellbeing along with functional weakening. Several studies have established the influence of gout and correlated situations on patient mortality and morbidity. In the common population, gout is still under-treated and under-diagnosed condition unfortunately. Despite great developments in treatment approaches, several patients with gout are inadequately controlled or inappropriately managed and consequently hyperuricemia flares are persistent. The advancement of innovative imaging interventions, urate-lowering treatments, and a well insight of the gout pathogenesis increase the prospect of improved treatment and better outcomes. In this narrative review, the recent advancements are spotlighted in the diagnostics and management of gout and hyperuricemia along with discussion on the innovative therapeutics.